Subscribe To
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Expands Clade’s pipeline and broadens its platform with:– proprietary gamma/delta (g/d) TCR universal targeting platform technology,– g/d TCR candidate integrated into Clade’s solid tumor pipeline BOSTON, Oct. 02, 2023 (GLOBE NEWSWIRE) — Clade Therapeutics (“Clade”), a biopharmaceutical company focused on discovering and delivering engineerable, off-the-shelf, scalable, and consistent stem cell-based medicines, today announced that it […] The post Clade Therapeutics Announces the Acquisition of...
Read More
Posted: Oct 2 2023, 12:30
Author Name: forextv
Views: 113047